Parkinson's disease (PD) is a degenerative neurological syndrome, which is characterized by the preferential death of dopaminergic (DAergic) neurons in the SubstantiaNigra. The pathogenesis of this disorder remains poorly understood and PD is still incurable. Currentdrug treatmentsare aimedprimarily for the treatmentof symptoms to improve the quality of life. Therefore, there is a need to find out new therapeutic strategies that not only provide symptomatic relief but also halt or reverse the neuronal damage hampering PD progression. Oxidative stress has been identified as one of the major contributors for the nigral loss in both sporadic and genetic forms of PD. In this review we first evaluate the current literature that link oxidative stress and mitochondrial dysfunction to PD. We then consider the results obtained through the treatmentof animal modelsor PD patients withmolecules that prevent oxidative stress or reduce mitochondrial dysfunction.

Anti-oxidants in Parkinson's disease therapy: a critical point of view

FILOGRANA, ROBERTA;BELTRAMINI, MARIANO;BUBACCO, LUIGI;BISAGLIA, MARCO
2016

Abstract

Parkinson's disease (PD) is a degenerative neurological syndrome, which is characterized by the preferential death of dopaminergic (DAergic) neurons in the SubstantiaNigra. The pathogenesis of this disorder remains poorly understood and PD is still incurable. Currentdrug treatmentsare aimedprimarily for the treatmentof symptoms to improve the quality of life. Therefore, there is a need to find out new therapeutic strategies that not only provide symptomatic relief but also halt or reverse the neuronal damage hampering PD progression. Oxidative stress has been identified as one of the major contributors for the nigral loss in both sporadic and genetic forms of PD. In this review we first evaluate the current literature that link oxidative stress and mitochondrial dysfunction to PD. We then consider the results obtained through the treatmentof animal modelsor PD patients withmolecules that prevent oxidative stress or reduce mitochondrial dysfunction.
File in questo prodotto:
File Dimensione Formato  
Bisaglia-revised1.pdf

accesso aperto

Tipologia: Preprint (submitted version)
Licenza: Accesso libero
Dimensione 531.72 kB
Formato Adobe PDF
531.72 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3172264
Citazioni
  • ???jsp.display-item.citation.pmc??? 29
  • Scopus 77
  • ???jsp.display-item.citation.isi??? 70
social impact